| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Clear collar is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HyGreen is a Gainesville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
WELL™ Health is upending the $3.5 trillion healthcare market by helping patients and administrators break free of antiquated communication practices. This 2021 Best in KLAS for Patient Outreach software provides medical organizations with a single command center that connects the many tools they use, transforming everyday interactions between patients and the doctor`s front office.
Hillsdale Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hillsdale, MI. To find more information about Hillsdale Community Health Center, please visit www.hchc.com